The Food and Drug Administration (FDA) is releasing new draft guidelines that are meant to streamline approvals for generic oral CBD medications.
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
The Food and Drug Administration (FDA) is releasing new draft guidelines that are meant to streamline approvals for generic oral CBD medications.
Illinois cannabis sales to out-of-state residents have nearly doubled since sales began in January from $8.6 million to $17.2 million in August, the Center Square reports.
Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)
Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)
Numinus starts psilocybon cultivation operations in its 7,000 sq ft Health Canada-licensed facility.
New research initiative will compare the efficacy of psilocybin with LSD.